DLL3 expression is a predictive marker of sensitivity to adjuvant chemotherapy for pulmonary LCNEC

BACKGROUND: The mammalian Notch family ligands delta‐like 3 (DLL3) is reported to be a potential therapeutic target for large cell neuroendocrine carcinomas (LCNEC). The effect of DLL3 expression on LCNEC prognosis has not yet been elucidated. METHODS: We reviewed the medical records of 70 LCNEC pat...

Descripción completa

Detalles Bibliográficos
Autores principales: Ogawa, Hiroyuki, Sakai, Yasuhiro, Nishio, Wataru, Fujibayashi, Yusuke, Nishikubo, Megumi, Nishioka, Yuki, Tane, Shinya, Kitamura, Yoshitaka, Sudo, Tamotsu, Sakuma, Toshiko, Yoshimura, Masahiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7471044/
https://www.ncbi.nlm.nih.gov/pubmed/32691982
http://dx.doi.org/10.1111/1759-7714.13574

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7471044/
https://www.ncbi.nlm.nih.gov/pubmed/32691982
http://dx.doi.org/10.1111/1759-7714.13574

Ejemplares similares